InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Murphy Kimberly M, 董事. Officer active across 2 companies, notably Clarus Therapeutics Holdings, Inc.. Cumulatively, 3 disclosures have been logged. Activity tracked since 12 December 2021. The latest transaction was disclosed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Murphy Kimberly M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
25,000 股0Common StockSEC:0001493152-23-027580:0
1,922 股0Common StockSEC:0000899243-22-021760:0
3,844 股0Common StockSEC:0000899243-21-048202:0
3 条申报中的 3 条
About Murphy Kimberly M
Kimberly M. Murphy is a Board Member of Clarus Therapeutics Holdings, Inc. In this role, she participates in the governance and strategy of the company. Her experience in the healthcare sector is a valuable asset to the board.
